Time-Restricted Eating Improved Kidney Function in a Small CKD Pilot Study: What the Research Shows

Time-Restricted Eating Improved Kidney Function in a Small CKD Pilot Study: What the Research Shows

Medical disclaimer: This article summarises published research for informational purposes only. It is not medical advice and is not a substitute for guidance from a qualified health professional. Always consult your doctor before starting any fasting protocol, especially if you have an existing health condition or take medication.

Study at a Glance

What This Study Looked At

Researchers wanted to know whether time-restricted eating (TRE) — confining food intake to a set daily window — could help overweight and obese adults with moderate-to-advanced chronic kidney disease (CKD stages 3-4), a population usually left out of fasting research because of safety concerns. The study measured whether an 8-hour eating window could improve kidney function, measured by estimated glomerular filtration rate (eGFR), compared with a standard control diet. If you're curious how fasting length affects the body more generally, see our guide to 12-hour vs 16-hour vs 24-hour fasting.

Who Was Studied

Participant profile: Overweight and obese adults with CKD stages 3-4, mean age approximately 52 years, just over half male, with a mean baseline eGFR of about 40.6 mL/min/1.73m² — placing the group solidly in moderate-to-severe kidney function impairment.

How the 8-hour TRF window worked in this study: Participants in the TRF group chose an 8-hour daily window in which to eat and fasted for the remaining 16 hours, without a prescribed calorie target. Group assignment was based on patient preference rather than random allocation, which is an important limitation covered below.

What the Researchers Found

Kidney Function (eGFR)

• The TRF group's kidney function, measured by eGFR, improved by an average of 3.1 mL/min/1.73m² over the 12-week study.
• The control group's eGFR moved in the opposite direction, declining by 0.8 mL/min/1.73m² over the same period — the typical trajectory expected in progressive CKD.
• This divergence is notable because CKD is usually a one-way, progressively worsening condition; any intervention that moves eGFR upward, even modestly, in a 12-week window is a meaningful signal.

Secondary Metabolic Markers

• Uric acid levels decreased significantly in the TRF group compared with the control group — relevant because elevated uric acid is linked to further kidney damage.
• Total protein levels increased significantly in the TRF group, a marker often associated with improved nutritional status.
• Body weight decreased significantly more in the TRF group than in the control group.

What Did Not Change

• The study also tracked gut microbiota composition and adverse events; the published pilot data did not report any serious adverse events attributable to the TRF protocol in this CKD population.
• Because this was a small pilot study, several secondary biochemical markers were tracked but not all reached statistical significance — the researchers themselves frame this as exploratory, hypothesis-generating data rather than confirmatory results.

What the Researchers Concluded

The authors concluded that an 8-hour time-restricted eating window appears feasible and safe for patients with CKD stages 3-4, and was associated with improved eGFR, reduced uric acid, and reduced body weight compared with a standard diet — a promising signal that warrants larger, randomized confirmation.

What This Means If You Fast

• This is not a green light to self-prescribe fasting for kidney disease. CKD is a condition where fluid balance, electrolytes, and medication timing all matter enormously — any fasting approach needs to be supervised by a nephrologist or physician.
• Time-restricted eating may support kidney-relevant metabolic markers. The uric acid and weight reductions seen here echo findings in healthier populations, discussed in our overview of fasting and weight loss.
• The eGFR improvement, while modest, runs against the expected direction of CKD. In a condition that normally only gets worse over time, even a small positive shift is clinically interesting.
• Weight loss appears to be a key driver. Since obesity itself is a risk factor for CKD progression, the greater weight loss in the TRF group may explain much of the kidney benefit.
• This is early-stage evidence, not a treatment protocol. People with CKD should not adopt an 8-hour eating window without medical supervision, particularly if on medications affected by meal timing.

Study Limitations

• Very small sample size (27 total participants, 13 in the TRF arm) — results need replication in a much larger cohort before they can be considered reliable.
• Participants were not randomized — they self-selected into the TRF or control group based on preference, which introduces potential selection bias (for example, more motivated or health-conscious participants may have chosen TRF).
• Short duration (12 weeks) — CKD progression and kidney adaptation happen over years, so long-term safety and durability of the eGFR improvement are unknown.
• Single-center study conducted in one hospital in Guangzhou, China, which may limit how well the findings generalize to other populations and healthcare settings.
• No information was reported on funding sources or conflicts of interest.

Source

Lao, B., Luo, J., Xu, X., Fu, L., Tang, F., Ouyang, W., Xu, X., Wei, M., Xiao, B., Chen, L., Wu, Y., & Liu, X. (2023). Time-restricted feeding's effect on overweight and obese patients with chronic kidney disease stages 3-4: A prospective non-randomized control pilot study. Frontiers in Endocrinology. PMID: 37082115

Frequently Asked Questions

Can intermittent fasting improve kidney function in CKD patients?

A small 2023 pilot study found that an 8-hour time-restricted eating window was associated with a 3.1 mL/min/1.73m² improvement in eGFR over 12 weeks, versus a decline in the control group — but this is early, non-randomized evidence, not a proven treatment.

Is fasting safe for people with chronic kidney disease?

This study reported no serious adverse events over 12 weeks, but CKD patients face specific risks around fluid balance, electrolytes, and medication timing, so fasting should only be attempted under medical supervision in this population.

What eating window did the study use?

Participants in the fasting group ate all their food within an 8-hour daily window and fasted for the remaining 16 hours, a schedule commonly known as 16:8.

Why did the control group's kidney function decline?

A gradual eGFR decline is the expected natural course of CKD stages 3-4 without intervention, which is why the TRF group's improvement stands out as notable even though the study was small.

Should I try time-restricted eating if I have CKD?

Only under the guidance of a nephrologist or physician. This pilot study is a promising early signal, not sufficient evidence on its own to justify unsupervised fasting in a CKD population.

Related Research and Articles

• Fasting and Kidney Health: Bright's Disease and Modern Kidney Research
• Fasting for Weight Loss: Why It's Not Just About Calories
• 12-Hour vs 16-Hour vs 24-Hour Fasting: What Happens at Each Stage
• Intermittent fasting and insulin resistance in women
• Who Should NOT Fast: Clear Contraindications and Cautions

Want the complete guide to fasting? Get Intermittent Fasting in Practice on Amazon — and claim 3 months free on our fasting app at fastinginpractice.com/redeem.